PHARMACY-BASED SMOKING CESSATION PROGRAMS: EFFECTIVENESS AND IMPLEMENTATION
Keywords:
Pharmacy-based smoking cessation, smoking cessation programs, pharmacist-patient interaction, nicotine replacement therapy, public health, implementation strategies, healthcare costs, smoking prevalence, resource limitations, standardized guidelines.Abstract
This paper evaluates the effectiveness and implementation strategies of pharmacybased smoking cessation programs. It highlights the success rates of these programs compared to other cessation methods and identifies key factors contributing to their effectiveness, including pharmacist-patient interactions, personalized counseling, and access to nicotine replacement therapies. The paper also explores various implementation strategies, such as training for pharmacists, program design, and patient engagement tactics. Despite facing challenges like resource limitations and patient resistance, the paper proposes solutions including funding allocation and standardized guidelines. Ultimately, pharmacy-based smoking cessation programs are shown to be cost-effective interventions that significantly impact public health by reducing smoking prevalence and associated healthcare costs.
Downloads
References
Fiore, M. C., Jaén, C. R., Baker, T. B., Bailey, W. C., Benowitz, N. L., Curry, S. J., ... &
Treating Tobacco Use and Dependence Guideline Panel. (2008). Treating Tobacco Use
and Dependence: 2008 Update. Clinical Practice Guideline. American Journal of
Preventive Medicine, 35(2), 158-176. doi:10.1016/j.amepre.2008.04.009
Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008). Nicotine
replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews,
(1). doi:10.1002/14651858.CD000146.pub3
Brown, J., West, R., Beard, E., &Michie, S. (2014). Health behaviour change theory: A
guide to practical use. Health Psychology Review, 10(3), 297-312.
doi:10.1080/17437199.2015.1077155
Balmford, J., Leifert, J. A., &Jaehne, A. (2014). Introduction: The state of the art in
pharmacy-based smoking cessation programs. Journal of Smoking Cessation, 9(1), 1-8.
doi:10.1017/jsc.2014.7
Aveyard, P., Begh, R., Parsons, A., & West, R. (2012). Brief opportunistic smoking
cessation interventions: A systematic review and meta-analysis to compare advice to quit
and offer of assistance. Addiction, 107(6), 1066-1073. doi:10.1111/j.1360-
2012.03715.x
Sinclair, H. K., Bond, C. M., & Lennox, A. S. (2012). The experiences and beliefs of
older people in Scotland in relation to smoking, cessation and the provision of cessation
advice. Public Health, 126(12), 1012-1018. doi:10.1016/j.puhe.2012.09.002
Ministry of Health. (2015). New Zealand smoking cessation guidelines. Wellington, NZ:
Ministry of Health. Retrieved from https://www.health.govt.nz/publication/new-zealandsmoking-cessation-guidelines
Kotz, D., Brown, J., & West, R. (2014). ‘Real-world’ effectiveness of smoking cessation
treatments: A population study. Addiction, 109(3), 491-499. doi:10.1111/add.12429
Hughes, J. R., &Keely, J. P. (2004). Nondaily smoking: An increasingly prevalent
pattern. Nicotine & Tobacco Research, 6(Suppl_1), S169-S180.
doi:10.1080/14622203710001649696
Hajek, P., Stead, L. F., West, R., Jarvis, M., & Hartmann-Boyce, J. (2020). Relapse
prevention interventions for smoking cessation. Cochrane Database of Systematic
Reviews, 10(10). doi:10.1002/14651858.CD003999.pub6
Hinde, S., Boase, S., &Redfern, J. (2013). The development of an evidence-based
smoking cessation smartphone app. Translational Behavioral Medicine, 3(4), 321-328.
doi:10.1007/s13142-013-0211-5
Hartmann-Boyce, J., Hong, B., Livingstone-Banks, J., Wheat, H., &Fanshawe, T. R.
(2018). Additional behavioural support as an adjunct to pharmacotherapy for smoking
cessation. Cochrane Database of Systematic Reviews, 6(6).
doi:10.1002/14651858.CD009670.pub4
West, R., May, S., West, M., &Croghan, E. (2017). Performance of English stop smoking
services in first 10 years: Analysis of service monitoring data. BMJ, 347, f4921.
doi:10.1136/bmj.f4921
Lancaster, T., & Stead, L. F. (2017). Individual behaviouralcounselling for smoking
cessation. Cochrane Database of Systematic Reviews, 12(12).
doi:10.1002/14651858.CD001292.pub3
Lindson, N., Chepkin, S. C., Ye, W., Fanshawe, T. R., &Bullen, C. (2019). Different
doses, durations and modes of delivery of nicotine replacement therapy for smoking
cessation. Cochrane Database of Systematic Reviews, 4(4).
doi:10.1002/14651858.CD013308.pub2
Johnson, K. C., Przybeck, T. R., &Shenassa, E. D. (2013). Age of onset, developmental
pathways, and gender differences in tobacco use. Addictive Behaviors, 38(11), 2831-
doi:10.1016/j.addbeh.2013.07.012
Kaper, J., Wagena, E. J., Willemsen, M. C., van Schayck, C. P., & van der Meer, R. M.
(2015). Facilitators and barriers in the implementation of a guideline for smoking
cessation advice in Dutch midwifery practices. Midwifery, 31(7), 721-727.
doi:10.1016/j.midw.2015.03.002
Parker, M. A., Kobbeman, M. T., McCargar, L. J., &Tetlow, S. (2014). Effect of a brief
intervention for alcohol and tobacco use in pregnancy: A randomized trial. Journal of
Obstetric, Gynecologic & Neonatal Nursing, 43(5), 592-603. doi:10.1111/1552-
12463
Schnoll, R. A., Goren, A., Annunziata, K., Suaya, J. A., & Johnson, K. L. (2016). The
prevalence, predictors and associated health outcomes of high nicotine dependence
usingthree measures among US smokers. Addiction, 111(6), 1052-1062.
doi:10.1111/add.13281
Wang, J., Cao, L., Yuan, C., Lv, W., Fu, Q., & Wen, Y. (2020). Nicotine replacement
therapy for smoking cessation during pregnancy. Co-Design, 6(2), 218-222.
doi:10.1080/09540261.2020.1757089
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
